360
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Morphological transformation induced by multiwall carbon nanotubes on Balb/3T3 cell model as an in vitro end point of carcinogenic potential

, , , , , , , , , , , , & show all
Pages 221-233 | Received 17 Jun 2011, Accepted 07 Dec 2011, Published online: 27 Jan 2012

References

  • Aschberger K, Johnston HJ, Stone V, Aitken RJ, Hankin SM, Peters SA, 2010. Review of carbon nanotubes toxicity and exposure-appraisal of human health risk assessment based on open literature. Crit Rev Toxicol 40:759–790.
  • Attal S, Thiruvengadathan R, Regev O. 2006. Determination of the concentration of single-walled carbon nanotubes in aqueous dispersions using UV-Visible absorption spectroscopy. Anal Chem 78:8098–8104.
  • Balls M, Clothier R. 2010. A FRAME response to the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects-2010. Altern Lab Anim 38:345–353.
  • Becker H, Herzberg F, Schulte A, Kolossa-Gehring M. 2011. The carcinogenic potential of nanomaterials, their release from products and options for regulating them. Int J Hyg Environ Health 214:231–238.
  • Buford MC, Hamilton RF, Holian A. 2007. A comparison of dispersing media for various engineered carbon nanoparticles. Part Fibre Toxicol 4:6–15.
  • Calzolai L, Gilliland D, Pascual Garcìa C, Rossi F. 2011. Separation and characterization of gold nanoparticle mixtures by flow-field-flow fractionation. J Chromatogr A 1218:4234–4239.
  • Casey A, Herzog E, Davoren M, Lyng FM, Byrne HJ, Chambers G. 2007. Spectroscopic analysis conforms the interactions between single walled carbon annotates and various dyes commonly used to assess cytotoxicity. Carbon 45:1425–1432.
  • Chou CC, Hsiao HY, Hong OS, Chun CH, Peng YW, Chen HW, 2008. Single-walled carbon nanotubes can induce pulmonary injury in mouse model. Nano Lett 8:437–445.
  • Colognato R, Ponti J, D'Errico MR, Migliore L, Rossi F. 2009. Genotoxicity assays analysis for carbon nanotubes: friends or foes? Preliminary results on human peripheral leukocytes. Int J Environ Health 3:275–284.
  • Comes Franchini M, Ponti J, Lemor R, Fournelle M, Broggi F, Locatelli E. 2010. Polymeric entrapped thiol-coated gold nanorods: cytotoxicity and suitability as molecular optoacoustic contrast agent. J Mater Chem 20:10908–10914.
  • Di Giorgio ML, Di Bucchianico S, Ragnelli AM, Aimola P, Santucci S, Poma A. 2011. Effects of single and multi walled carbon nanotubes on macrophages: cyto and genotoxicity and electron microscopy. Mutat Res 18:20–31.
  • Di Sotto A, Chiaretti M, Carru GA, Bellucci S, Mazzanti G. 2009. Multi-walled carbon nanotubes: lack of mutagenic activity in the bacterial reverse mutation assay. Toxicol Lett 184:192–197.
  • Ding L, Stilwell J, Zhang T, Elboudwarej O, Jiang H, Selegue JP, 2005. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett 5:2448–2464.
  • Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, 2006. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 92:5–22.
  • Donaldson K, Murphy FA, Duffin R, Poland CA. 2010. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010:7–5.
  • Duffin R, Tran L, Brown D, Stone V, Ken D. 2007. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19:849–856.
  • Fenoglio I, Greco G, Tomatis M, Muller J, Raymundo-Piñero E, Béguin F, 2008. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: physicochemical aspects. Chem Res Toxicol 21:1690–1697.
  • Genaidy A, Tolaymat T, Sequeira R, Rinder M, Dionysiou D. 2009. Health effects of exposure to carbon nanofibers: systematic review, critical appraisal, meta analysis and research to practice perspectives. Sci Total Environ 407:3686–3701.
  • Girifalco L, Hodak M, Lee RS. 2000. Carbon nanotubes, buckyballs, ropes, and a universal graphitic potential. J Phys Rev B 62:13104–13110.
  • Hesterberg TW, Barrett JC. 1984. Dependence of Asbestos- and mineral dust-induced transformation of mammalian cells in culture on fiber dimension. Cancer Res 44:2170–2180.
  • IARC. 1987. Monographs on the evaluation of carcinogenic risks to humans, overall evaluation of carcinogenicity: an updating of IARC monographs vols. 1 to 42. Suppl. 7, p 109.
  • IARC/NCI/EPA Working-Group. 1985. Cellular and molecular mechanisms of cell transformation and standardization of transformation assays of established cell lines for the prediction of carcinogenic chemicals: overview and recommended protocols. Cancer Res 45:2395–2399.
  • INTELTEX project web site [Online]http://www.inteltex.eu. Accessed on 12 October 2011.
  • Isfort RJ, LeBoeuf RA. 1996. Application of in vitro cell transformation assays to predict the carcinogenic potential of chemicals. Mutation Research/Reviews in Genetic Toxicology 365:161–173.
  • Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, 2010. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics. Nanotoxicology 4:207–246.
  • JRC Projects web site [Online]http://projects.jrc.ec.europa.eu/jpb_public/act/publicexportworkprogramme.html?objTypeCombo=&actId=188. Accessed on 11 October 2011.
  • Kam NW, O'Connell M, Wisdom JA, Dai H. 2005. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 102:11600–11605.
  • Kerckaert GA, Brauninger R, LeBoeuf RA, Isfort RJ. 1996. Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays. Environ Health Perspect 104:1075–1084.
  • Kurzepa H, Kyriazis AP, Lang DR. 1984. Growth characteristics of tumors induced by transplantation into athymic mice of BALB/3T3 cells transformed in vitro by residue organics from drinking water. J Environ Pathol Toxicol Oncol 5:131–138.
  • Lam CW, James JT, McCluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126–134.
  • LANGSRUD web site [Online]http://www.langsrud.com/fisher.htm. Accessed on 11 October 2011.
  • Lin F, Liu Y, Liu Y, Keshava N, Li S. 2000. Crocidolite induces cell transformation and p53 gene mutation in BALB/c-3T3 cells. Teratog Carcinog Mutagen 20:273–281.
  • Lison D, Leen CJ, Thomassen Rabolli V, Gonzalez L, Napierska D, Seo JW, 2008. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol Sci 104:155–162.
  • Madl AK, Pinkerton KE. 2009. Health effects of inhaled engineered and incidental nanoparticles. Crit Rev Toxicol 39:629–658.
  • Ma-Hock L, Treumann S, Strauss V, Brill S, Luizi F, Mertler M, 2009. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol Sci 112:468–481.
  • Mazzotti F, Sabbioni E, Ponti J, Ghiani M, Fortaner S, Rossi GL. 2002. In vitro setting of dose-effect relationships of 32 metal compounds in the Balb/3T3 cell line, as a basis for predicting their carcinogenic potential. ATLA 30:209–217.
  • Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticles toxicity in a human cell line. Toxicol Appl Pharmacol 234:222–235.
  • Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. 2005. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 15:377–384.
  • Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D. 2009. Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci 110:442–448.
  • Muller J, Huaux F, Fonseca A, Nagy JB, Moreau N, Delos M, 2008. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chem Res Toxicol 21:1698–1705.
  • Muller J, Huaux F, Moreau N, Misson P, Heilier J-F, Delos M, 2005. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 207:221–231.
  • Nagai H, Toyokuni S. 2010. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from Asbestos toward safety of fibrous nanomaterials. Arch Biochem Biophys 502:1–7.
  • Nanocyl web site [Online]www.nanocyl.com. Accessed on 18 October 2011.
  • Oberdörster E. 2004. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 112:1058–1062.
  • Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8–43.
  • Oberdörster G. 2000. Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int Arch Occup Environ Health 73:60–68.
  • OECD. 1981a. Guideline 451. Carcinogenicity studies (17 pages; adopted 12 May 1981). OECD Guidelines for the Testing of Chemicals (1993) Section 4: Health effects. Vol. 2. Paris: Organisation for Economic Cooperation & Development.
  • Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, 2008. Carbon nanotubes introduced into the abdominal cavity of mice show Asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423–428.
  • Ponti J, Colognato R, Rauscher H, Gioria S, Broggi F, Franchini F, 2010. Colony Forming Efficiency and microscopy analysis of multi-wall carbon nanotubes cell interaction. Toxicol Lett 197:29–37.
  • Ponti J, Munaro B, Fischbach M, Hoffmann S, Sabbioni E. 2007. An Optimised data analysis for Balb/c 3T3 cell transformation assay and its application to metal compounds. Int J Immunopathol Pharmacol 20:673–684.
  • Ponti J, Sabbioni E, Munaro B, Broggi F, Marmorato P, Franchini F, 2009. Genotoxicity and morphological transformation induced by cobalt nanoparticles and cobalt chloride: an in vitro study in Balb/3T3 mouse fibroblasts. Mutagenesis 24:439–445.
  • Ponti J. 2004. In vitro metal toxicology research: a study carried out by Balb/3T3, HaCaT and Caco-2 cell lines: report of research activity [dissertation]. Barcelona (SP): Universitat Autònoma de Barcelona, Facultat de Ciències, 97pp. T-575 2004 Ponti [Online]. http://publications.jrc.ec.europa.eu/repository/handle/111111111/13708. Accessed on 11 October 2011.
  • Porter AE, Gass M, Muller K, Skepper JN, Midgley PA, Welland M. 2007. Direct imaging of single-walled carbon nanotubes in cells. Nat Nanotechnol 11:713–717.
  • Raffa V, Ciofani G, Vittorio O, Riggio C, Cuschieri A. 2010. Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine 5:89–97.
  • Regulation (EC) 440/2008 of 30 May 2008 Laying Down Test Methods Pursuant to Regulation (EC) 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH). Official Journal of the European Union, 31 May 2008, vol. 51, L142/1–L142/739.
  • Rivas GA, Rubianes MD, Rodriguez MC, Ferreyra NF, Luque GL, Pedano ML, 2007. Carbon nanotubes for electrochemical biosensing. Talanta 74:291–307.
  • Rotoli BM, Bussolati O, Bianchi MG, Barilli A, Balasubramanian C, Bellucci S, 2008. Non-functionalized multi-walled carbon nanotubes alter the paracellular permeability of human airway epithelial cells. Toxicol Lett 5:95–102.
  • Rotoli BM, Bussolati O, Barilli A, Zanello PP, Bianchi MG, Magrini A, 2009. Airway barrier dysfunction induced by exposure to carbon nanotubes in vitro: which role for fibre length? Hum Exp Toxicol 28:361–368.
  • Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley-Phillips JK, Everitt JI, Tewksbury EW, 2009. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol 4:747–751.
  • Saffiotti U, Ahmed N. 1995. Neoplastic transformation by quartz in the BALB/3T3/A31-1-1 cell line and the effects of associated minerals. Teratog Carcinog Mutagen 15:339–356.
  • Soto K, Garza KM, Murr LE. 2007. Cytotoxic effects of aggregated nanomaterials. Acta Biomater 3:351–358.
  • Swierenga SH, Yamasaki H. 1992. Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity. In: Vainio H, Magee PN, McGregor DB, McMichael AJ, editors. Mechanisms of carcinogenesis in risk identification. Lyon, New York: IARC. pp 165–193.
  • Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, 2008. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 33:105–116.
  • Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. 2007. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity Assessments. Toxicol Sci 95:300–312.
  • Thurnherr T, Brandenberger C, Fischer K, Diener L, Manser P, Maeder-Althaus X, 2011. A comparison of acute and long-term effects of industrial multiwalled carbon nanotubes on human lung and immune cells in vitro. Toxicol Lett 200:176–186.
  • Vanparys P, Corvi R, Aardema M, Gribaldo L, Hayashi M, Hoffmann S, 2010. Results of ECVAM prevalidation study of three cell transformation assays. ALTEX 27:267–270.
  • Walker C, Everitt J, Barrett JCPossible cellular and molecular mechanisms for Asbestos carcinogenicity. 1992. Am J Ind Med 21:253–273.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.